EMILY EZRA: Open Payments
NPI 1538907639 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $380 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $298 |
| Gilead Sciences, Inc. | 5 | $209 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| ViiV Healthcare Company | 3 | $67 |
| Exact Sciences Corporation | 2 | $52 |
| ABBVIE INC. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Seqirus USA Inc | 1 | $27 |
| Exeltis, USA Inc. | 1 | $21 |
Products named: AIRSUPRA, Yeztugo, REXULTI, APRETUDE, NEXIUM, VRAYLAR, SHINGRIX, Wegovy.
Industry payments across CO — which companies pay providers there.
